Effect of L-carnitine supplementation on lipid accumulation product and cardiovascular indices in women with overweight/obesity who have knee osteoarthritis: a randomized controlled trial

Table 2 Anthropometric parameters and energy intake in women with knee osteoarthritis

Variables	L-carnitine (n = 38)	Placebo (n = 38)	P^†
Weight, kg
Baseline	78.69 ± 10.86	78.90 ± 12.17	0.93
Week 12	76.22 ± 11.06	77.05 ± 12.48	0.75
P	< 0.001	< 0.001
Mean difference	− 2.47 ± 1.81	− 1.85 ± 1.74	0.13
BMI, kg/m²
Baseline	33.03 ± 6.67	32.10 ± 4.29	0.47
Week 12	31.95 ± 6.32	31.35 ± 4.39	0.63
P	< 0.001	< 0.001
Mean difference	− 1.08 ± 0.87	− 0.75 ± 0.7	0.07
WC, cm
Baseline	105.13 ± 9.04	105.92 ± 10.57	0.72
Week 12	99.81 ± 11.17	102.47 ± 10.32	0.28
P	< 0.001	< 0.001
Mean difference	− 5.32 ± 5.60	− 3.45 ± 3.38	0.08
Energy intake, Kcal
Baseline	1426.21 ± 344.91	1377.72 ± 406.44	0.57
Week 12	1325.18 ± 154.48	1333.88 ± 153.92	0.80
P	0.11	0.52
Mean difference	− 101.03 ± 388.86	− 43.84 ± 417.09	0.53

P values are computed by independent t-test and data are expressed as mean ± standard deviation (SD)
P: resulted from within each group comparison
P^†: resulted from comparing the means of each variable at the end of the study, between groups
BMI: body mass index; WC: waist circumference

ISSN: 2520-1026